Aquestive Therapeutics, Inc.
AQSTNasdaq
$4.12
↑ +4.6%Jul 17 close · end-of-day
Price
1Y↑ +2.2%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$505.2M
Enterprise Value
$419.5M
P/E
—
P/S
10.0
P/B
—
EV/EBITDA
—
PEG
—
FCF Yield
-8.8%
Dividend Yield
—
Revenue (TTM)
$50.3M
Net Income (TTM)
-$68.9M
Free Cash Flow (TTM)
-$44.3M
Gross Margin
—
Operating Margin
-111.2%
Net Margin
-137.1%
ROE
202.4%
ROIC
—
Debt / Equity
-0.7
Net Cash
$85.6M
Return 1Y
-5.7%
Company profile
Aquestive Therapeutics, Inc. focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formant of buprenorphine and naloxone for the. treatment of opioid dependence.
- CEO
- Daniel Barber
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 160
- Headquarters
- New Jersey
- Website
- aquestive.com
Management & directors
- Barber DanielPresident and CEO
- Korczynski SherryChief Commercial Officer
- Zalewski Thomas A.Chief Legal Officer
- Cioffi MelinaSVP, Regulatory Affairs
- Braender Lori JCorporate Secretary
- Boyd Peter E.Chief People Officer
- Jung CassieChief Operating Officer
- Toth A Ernest JrChief Financial Officer
- Davis Matthew W.Chief Development Officer
- Greenhawt Matthew J.Chief Medical Officer
- Kraus Carl NChief Medical Officer
Roles derived from SEC Form 4 filings.
Earnings
AQST Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$14.4M↑ +65.7%
Diluted EPS-$0.07↓ -70.8%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $45.8M | $50.8M | $47.7M | $50.6M | $57.6M | $44.5M |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$42.9M | -$34.7M | -$42.1M | -$15.1M | -$30.8M | -$71.1M |
| Net income | -$55.8M | -$70.5M | -$54.4M | -$7.9M | -$44.1M | -$83.8M |
| Diluted EPS | -$1.66 | -$1.85 | -$1.12 | -$0.13 | -$0.51 | -$0.78 |
| Operating cash flow | -$45.5M | -$33.0M | -$9.8M | -$6.4M | -$35.8M | -$52.4M |
| Free cash flow | -$46.0M | -$33.9M | -$10.8M | -$7.4M | -$35.9M | -$53.0M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -93.6% | -68.2% | -88.2% | -29.9% | -53.5% | -159.5% |
| Net margin | -121.7% | -138.8% | -114.1% | -15.6% | -76.7% | -188.1% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.1M | $13.5M | $11.9M | $8.7M | $10.0M | $12.8M | $13.0M | $14.4M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $55,000.00 | -$8.3M | -$13.6M | -$19.4M | -$11.4M | -$11.5M | -$28.8M | -$4.2M |
| Net income | -$2.7M | -$11.5M | -$17.1M | -$22.9M | -$13.5M | -$15.4M | -$31.9M | -$8.1M |
| Diluted EPS | -$0.03 | -$0.13 | -$0.18 | -$0.24 | -$0.14 | -$0.14 | -$0.26 | -$0.07 |
| Operating cash flow | -$7.0M | -$11.9M | -$6.5M | -$23.4M | -$7.9M | -$12.6M | -$8.5M | -$14.8M |
| Free cash flow | -$7.0M | -$12.0M | -$6.5M | -$23.5M | -$8.0M | -$12.9M | -$8.6M | -$14.9M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 0.3% | -61.2% | -114.4% | -222.1% | -113.6% | -89.6% | -221.6% | -29.1% |
| Net margin | -13.7% | -85.0% | -143.7% | -263.0% | -135.4% | -120.6% | -244.8% | -55.8% |
Company news
Jun 24, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-16 | Barber Daniel· President and CEO | Sale | 20,369 | $4.00 | $81,508.59 | filing |
| 2026-07-15 | Barber Daniel· President and CEO | Sale | 4,631 | $4.03 | $18,683.31 | filing |
| 2026-06-23 | Krop Julie | Sale | 25,000 | $5.02 | $125,392.50 | filing |
| 2026-06-23 | Krop Julie | Option exercise | 25,000 | $0.71 | $17,830.00 | filing |
| 2026-06-15 | Barber Daniel· President and CEO | Sale | 25,000 | $4.16 | $104,010.00 | filing |
| 2026-06-08 | Korczynski Sherry· Chief Commercial Officer | Tax withholding | 2,714 | $0.00 | $0.00 | filing |
| 2026-05-18 | Zalewski Thomas A.· Chief Legal Officer | Award | 100,000 | $0.00 | $0.00 | filing |
| 2026-05-15 | Barber Daniel· President and CEO | Sale | 8,257 | $4.29 | $35,413.45 | filing |
| 2026-05-15 | Cioffi Melina· SVP, Regulatory Affairs | Tax withholding | 1,667 | $4.17 | $6,951.39 | filing |
| 2026-05-07 | BRAENDER LORI J· Corporate Secretary | Tax withholding | 135,690 | $4.23 | $573,968.70 | filing |
| 2026-05-05 | Barber Daniel· President and CEO | Tax withholding | 335,922 | $4.18 | $1.4M | filing |
| 2026-05-05 | TOTH A ERNEST JR· Chief Financial Officer | Tax withholding | 92,652 | $4.18 | $387,285.36 | filing |
| 2026-05-05 | BRAENDER LORI J· Corporate Secretary | Tax withholding | 76,147 | $4.18 | $318,294.46 | filing |
| 2026-05-05 | Jung Cassie· Chief Operating Officer | Tax withholding | 72,734 | $4.18 | $304,028.12 | filing |
| 2026-05-05 | Boyd Peter E.· Chief People Officer | Tax withholding | 56,778 | $4.18 | $237,332.04 | filing |
| 2026-03-10 | Barber Daniel· President and CEO | Sale | 180,677 | $4.17 | $753,965.12 | filing |
| 2026-03-10 | TOTH A ERNEST JR· Chief Financial Officer | Sale | 58,254 | $4.17 | $243,093.94 | filing |
| 2026-03-10 | Jung Cassie· Chief Operating Officer | Sale | 45,791 | $4.17 | $191,085.84 | filing |
| 2026-03-10 | BRAENDER LORI J· Chief Legal Officer | Sale | 40,102 | $4.17 | $167,345.65 | filing |
| 2026-03-10 | Boyd Peter E.· Chief People Officer | Sale | 29,814 | $4.17 | $124,413.82 | filing |
| 2026-03-10 | Cioffi Melina· SVP, Regulatory Affairs | Sale | 25,311 | $4.17 | $105,622.80 | filing |
| 2026-03-10 | Korczynski Sherry· Chief Commercial Officer | Sale | 15,741 | $4.17 | $65,687.19 | filing |
| 2026-03-09 | Barber Daniel· President and CEO | Award | 262,000 | $0.00 | $0.00 | filing |
| 2026-03-09 | BRAENDER LORI J· Chief Legal Officer | Award | 80,000 | $0.00 | $0.00 | filing |
| 2026-03-09 | Cioffi Melina· SVP, Regulatory Affairs | Award | 100,000 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.